Bravecto kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis), and the treatment and control of tick infestations [Ixodes scapularis (black-legged tick), Dermacentor variabilis (American dog tick), and Rhipicephalus sanguineus (brown dog tick)] for 12 weeks in dogs and puppies 6 months of age and older, and weighing 4.4 pounds or greater. Works as early as 12 weeks.
Bravecto is also indicated for the treatment and control of Amblyomma americanum (lone star tick) infestations for 8 weeks in dogs and puppies 6 months of age and older, and weighing 4.4 pounds or greater.
This product is safe for breeding, pregnant and lactating dogs.
Small dogs (9.9lb to 22lb): 250mg Fluraliner
Medium dogs (22lb to 44lb): 500mg Fluraliner
Large dogs (44lb to 88lb): 1000mg Fluraliner
Dosage and administration:
Bravecto should be administered orally as a single dose every 12 weeks to provide a minimum dose of 11.4mg/lb (25mg/kg) body weight. Bravecto may be administered every 8 weeks in case of potential exposure to Amblyomma americanum ticks.
Bravecto should be administered with food. Treatment with Bravecto may begin at any time of the year and can continue year round without interruption.
Bravecto has not been shown to be effective for 12-weeks duration in puppies less than 6 months of age. Bravecto is not effective against Amblyomma americanum ticks beyond 8 weeks after dosing.
Not for human use. Keep out of reach of children.
Do not store above 30°C (86°F).